ALEMBIC PHARMACEUTICALS Financial Statement Analysis
|
||
|
The Revenues of ALEMBIC PHARMACEUTICALS have increased by 10.19% YoY .
The Earnings Per Share (EPS) of ALEMBIC PHARMACEUTICALS has decreased by -5.27 % YoY. |
||
ALEMBIC PHARMACEUTICALS Last 5 Annual Financial Results
[BOM: 533573|NSE : APLLTD]
| Consolidated | Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 |
|---|---|---|---|---|---|
| Revenues | ₹6,229 Cr | ₹5,653 Cr | ₹5,306 Cr | ₹5,393 Cr | ₹4,606 Cr |
| Expenses | ₹5,296 Cr | ₹4,945 Cr | ₹4,432 Cr | ₹3,913 Cr | ₹3,392 Cr |
| Operating Profit (Excl OI) | ₹933 Cr | ₹708 Cr | ₹874 Cr | ₹1,480 Cr | ₹1,214 Cr |
| Other Income | ₹29 Cr | ₹3.04 Cr | ₹50 Cr | ₹87 Cr | ₹14 Cr |
| Interest | ₹56 Cr | ₹50 Cr | ₹18 Cr | ₹16 Cr | ₹27 Cr |
| Depreciation | ₹273 Cr | ₹275 Cr | ₹287 Cr | ₹183 Cr | ₹157 Cr |
| Profit Before Tax | ₹632 Cr | ₹355 Cr | ₹625 Cr | ₹1,368 Cr | ₹1,000 Cr |
| Profit After Tax | ₹616 Cr | ₹342 Cr | ₹521 Cr | ₹1,115 Cr | ₹801 Cr |
| Consolidated Net Profit | ₹616 Cr | ₹342 Cr | ₹521 Cr | ₹1,147 Cr | ₹829 Cr |
| Earnings Per Share (Rs) | ₹29.68 | ₹31.33 | ₹17.40 | ₹26.50 | ₹58.33 |
| PAT Margin (%) | 8.72 | 9.89 | 6.05 | 9.82 | 20.67 |
| ROE(%) | 11.63 | 13.40 | 7.12 | 10.11 | 26.91 |
| ROCE(%) | 13.51 | 13.42 | 7.44 | 11.25 | 26.28 |
| Total Debt/Equity(x) | 0.23 | 0.09 | 0.15 | 0.12 | 0.10 |
Key Financials |
||
| Market Cap | : | ₹ 15,763.4 Cr |
| Revenue (TTM) | : | ₹ 7,266.8 Cr |
| Net Profit(TTM) | : | ₹ 627.5 Cr |
| EPS (TTM) | : | ₹ 31.9 |
| P/E (TTM) | : | 25.1 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| ALEMBIC PHARMACEUTICALS | 0.4% | 0.2% | -9.6% |
| SUN PHARMACEUTICAL INDUSTRIES | 0.2% | -1.3% | -3.5% |
| DIVIS LABORATORIES | 1.9% | -6.7% | 0.4% |
| CIPLA | 1.3% | -8.5% | -7.3% |
| TORRENT PHARMACEUTICALS | 1.3% | 2.9% | 28.7% |
| DR REDDYS LABORATORIES | 1.3% | 3.8% | 4.5% |
| MANKIND PHARMA | -0.9% | -5.8% | -18.4% |
| ZYDUS LIFESCIENCES | -2% | -0.9% | -5.2% |
| LUPIN | 0.5% | 1.1% | 4.2% |
ALEMBIC PHARMACEUTICALS Revenues
[BOM: 533573|NSE : APLLTD]
| Y-o-Y | 10.19 % |
| 5 Yr CAGR | 7.84 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2025 | ₹6,229 Cr | 10.19 | |
| Mar2024 | ₹5,653 Cr | 6.54 | |
| Mar2023 | ₹5,306 Cr | -1.62 | |
| Mar2022 | ₹5,393 Cr | 17.10 | |
| Mar2021 | ₹4,606 Cr | - | |
ALEMBIC PHARMACEUTICALS Operating Profit
[BOM: 533573|NSE : APLLTD]
| Y-o-Y | 31.72 % |
| 5 Yr CAGR | -6.38 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹933 Cr | 31.72 | |
| Mar2024 | ₹708 Cr | -19.00 | |
| Mar2023 | ₹874 Cr | -40.94 | |
| Mar2022 | ₹1,480 Cr | 21.91 | |
| Mar2021 | ₹1,214 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 19.47 % |
| 5 Yr CAGR | -13.19 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2025 | 14.97% | 19.47 | |
| Mar2024 | 12.53% | -23.97 | |
| Mar2023 | 16.48% | -39.94 | |
| Mar2022 | 27.44% | 4.10 | |
| Mar2021 | 26.36% | - | |
ALEMBIC PHARMACEUTICALS Profit After Tax
[BOM: 533573|NSE : APLLTD]
| Y-o-Y | 80.07 % |
| 5 Yr CAGR | -7.16 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹616 Cr | 80.07 | |
| Mar2024 | ₹342 Cr | -34.35 | |
| Mar2023 | ₹521 Cr | -54.56 | |
| Mar2022 | ₹1,147 Cr | 38.33 | |
| Mar2021 | ₹829 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | -11.83 % |
| 5 Yr CAGR | -19.41 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2025 | 8.72 % | -11.83 | |
| Mar2024 | 9.89 % | 63.47 | |
| Mar2023 | 6.05 % | -38.39 | |
| Mar2022 | 9.82 % | -52.49 | |
| Mar2021 | 20.67 % | - | |
ALEMBIC PHARMACEUTICALS Earnings Per Share (EPS)
[BOM: 533573|NSE : APLLTD]
| Y-o-Y | -5.27 % |
| 5 Yr CAGR | -15.54 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2025 | ₹30 | -5.27 | |
| Mar2024 | ₹31 | 80.06 | |
| Mar2023 | ₹17 | -34.34 | |
| Mar2022 | ₹27 | -54.57 | |
| Mar2021 | ₹58 | - | |
ALEMBIC PHARMACEUTICALS Return on Capital Employed (ROCE)
[BOM: 533573|NSE : APLLTD]
| Y-o-Y | 0.67 % |
| 5 Yr CAGR | -15.32 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2025 | 13.51% | 0.67 | |
| Mar2024 | 13.42% | 80.38 | |
| Mar2023 | 7.44% | -33.87 | |
| Mar2022 | 11.25% | -57.19 | |
| Mar2021 | 26.28% | - | |
ALEMBIC PHARMACEUTICALS Share Price vs Sensex
| Current Share Price | : | ₹801.8 |
| Current MarketCap | : | ₹ 15,763.4 Cr |
| Updated EOD on | : | Feb 10,2026 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALEMBIC PHARMACEUTICALS | 0.4% |
0.2% |
-9.6% |
| SENSEX | 0.6% |
0.1% |
9.2% |
ALEMBIC PHARMACEUTICALS related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE ALLCAP | 6.4% | 8.9% | 7.5% |
| BSE MIDSMALLCAP | 4.7% | 9% | 8.4% |
| BSE 500 SHARIAH | 4.3% | 4.3% | 1.1% |
| BSE 250 SMALLCAP INDEX | 2.2% | -1.4% | 3.1% |
| BSE 400 MIDSMALLCAP INDEX | 2% | -0.3% | 8.4% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY SMALLCAP 250 | 2.4% | -0.9% | 4.3% |
| NIFTY 500 EQUAL WEIGHT | 2.3% | -0.1% | 7.9% |
| NIFTY MIDSMALLCAP 400 | 2.3% | 0.2% | 10.7% |
| NIFTY500 LARGEMIDSMALL EQUAL-CAP WEIGHTED INDEX | 1.9% | 0.1% | 10% |
| NIFTY500 MULTICAP 50:25:25 | 1.6% | 0.2% | 10.3% |
You may also like the below Video Courses
FAQ about ALEMBIC PHARMACEUTICALS Financials
How the annual revenues of ALEMBIC PHARMACEUTICALS have changed ?
The Revenues of ALEMBIC PHARMACEUTICALS have increased by 10.19% YoY .
How the Earnings per Share (EPS) of ALEMBIC PHARMACEUTICALS have changed?
The Earnings Per Share (EPS) of ALEMBIC PHARMACEUTICALS has decreased by -5.27 % YoY .
Check out Intrinsic Value of Peers of ALEMBIC PHARMACEUTICALS
Compare Stock Analytics of Peers of ALEMBIC PHARMACEUTICALS
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs
